Browse the full record of transactions filed by CHILDS JOHN W, Director. Officer active across 3 companies, notably Veradermics, Inc. Cumulatively, 8 reports have been published. Total volume traded: €10.9m. The latest transaction was disclosed on 4 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
John W. Childs is a Board Member at Veradermics, Inc., Biohaven Ltd., and Biohaven Pharmaceutical Holding Co Ltd. He contributes to the governance of all three companies, bringing his expertise in management and strategy. His commitment to innovation is essential for long-term success.